We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $733M
1-Year Est. Return 327.32%
This Fund
S&P 500
This Quarter Est. Return
+56.71%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
–
AUM
$733M
AUM Growth
+$320M
Cap. Flow
+$252M
Cap. Flow %
34.37%
Top 10 Hldgs %
68.14%
Holding
51
New
17
Increased
14
Reduced
5
Closed
8

Top Buys

1
SIMO icon
Silicon Motion
SIMO
+$24.3M
2
TYGO icon
Tigo Energy
TYGO
+$24.1M
3
ZBRA icon
Zebra Technologies
ZBRA
+$23.5M
4
APPS icon
Digital Turbine
APPS
+$21M
5
GNRC icon
Generac Holdings
GNRC
+$17.3M

Top Sells

1
SNDK
Sandisk
SNDK
+$45.2M
2
DAWN
Day One Biopharmaceuticals
DAWN
+$18.6M
3
DOMO icon
Domo
DOMO
+$15.5M
4
BKTI icon
BK Technologies
BKTI
+$14.5M
5
LASR icon
nLIGHT
LASR
+$14.1M

Sector Composition

1 Technology 35.44%
2 Healthcare 26.63%
3 Industrials 4.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWM icon
1
PUT
iShares Russell 2000 ETF
IWM
$82.2B
$149M 20.29%
+600,000
New +$155M
SNDK
2
Sandisk
SNDK
$209B
$127M 17.33%
200,000
-80,000
-29% -$45.2M
ZM icon
3
CALL
Zoom
ZM
$27.2B
$56.3M 7.67%
700,000
– –
XLK icon
4
PUT
State Street Technology Select Sector SPDR ETF
XLK
$114B
$39.9M 5.44%
+300,000
New +$42.3M
TYGO icon
5
Tigo Energy
TYGO
$132M
$27.4M 3.73%
+7,280,312
New +$24.1M
SIMO icon
6
Silicon Motion
SIMO
$9.24B
$22.5M 3.06%
+200,000
New +$24.3M
ZBRA icon
7
Zebra Technologies
ZBRA
$12.6B
$20.9M 2.85%
+100,000
New +$23.5M
LASR icon
8
nLIGHT
LASR
$3.71B
$19.4M 2.64%
340,000
-260,103
-43% -$14.1M
VNDA icon
9
Vanda Pharmaceuticals
VNDA
$328M
$19M 2.59%
2,750,000
+751,569
+38% +$5.8M
PSNL icon
10
Personalis
PSNL
$1.63B
$18.5M 2.52%
2,900,000
– –
GNRC icon
11
Generac Holdings
GNRC
$12.7B
$17.6M 2.4%
+90,000
New +$17.3M
KYTX icon
12
Kyverna Therapeutics
KYTX
$452M
$17.3M 2.35%
2,000,000
+500,000
+33% +$4.17M
CSTL icon
13
Castle Biosciences
CSTL
$735M
$14.5M 1.98%
590,601
-34,118
-5% -$1.12M
APPS icon
14
Digital Turbine
APPS
$1.04B
$14.1M 1.92%
+4,895,772
New +$21M
RRX icon
15
Regal Rexnord
RRX
$14.1B
$14M 1.92%
+75,000
New +$13.9M
ABEO icon
16
Abeona Therapeutics
ABEO
$400M
$13.9M 1.89%
3,100,000
+1,100,000
+55% +$5.5M
LRMR icon
17
Larimar Therapeutics
LRMR
$381M
$13.5M 1.84%
3,000,000
+1,000,000
+50% +$4M
FENC icon
18
Fennec Pharmaceuticals
FENC
$363M
$12.2M 1.66%
1,981,501
+400,000
+25% +$3.09M
ESPR
19
DELISTED
Esperion Therapeutics
ESPR
$12.1M 1.64%
4,400,000
+400,000
+10% +$1.27M
ZVRA icon
20
Zevra Therapeutics
ZVRA
$754M
$11.2M 1.53%
+1,200,000
New +$10.8M
BDSX icon
21
Biodesix
BDSX
$207M
$11M 1.5%
+758,328
New +$9.4M
IDN icon
22
Intellicheck
IDN
$75.9M
$10.6M 1.45%
1,517,249
+303,815
+25% +$1.65M
VSTM icon
23
Verastem
VSTM
$507M
$10.6M 1.45%
+2,000,000
New +$12.3M
TARA icon
24
Protara Therapeutics
TARA
$229M
$8.45M 1.15%
+1,622,733
New +$9.6M
VUZI icon
25
Vuzix
VUZI
$193M
$7.61M 1.04%
+3,295,754
New +$9M
1
2 3

Similar funds

GFI
Global Frontier Investments Charleston, South Carolina $732M AUM 8.6% 1-Year Est. Return
RP
Rice Partnership Honolulu, Hawaii $732M AUM 28.13% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $732M AUM 29.73% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
GIC
GFI Investment Counsel Toronto, Ontario, Canada $731M AUM 3.86% 1-Year Est. Return
CT
Colonial Trust Spartanburg, South Carolina $735M AUM 18% 1-Year Est. Return
TWP
TFO Wealth Partners Maumee, Ohio $735M AUM 21.07% 1-Year Est. Return
GWS
Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return

AIGH Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, AIGH Capital Management held 51 positions worth $733M, up 77% from $413M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

AIGH Capital Management deployed $252M of net new capital in Q1 2026, opening 17 new positions and adding to 14 existing holdings. Its largest new stake was Silicon Motion: 200,000 shares worth $22.5M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Sandisk, an estimated $45.2M trimmed.

  • AIGH Capital Management's largest Q1 2026 buy was Silicon Motion: 200,000 shares worth $22.5M.
  • AIGH Capital Management added most to Vanda Pharmaceuticals in Q1 2026, an estimated $5.8M increase.
  • AIGH Capital Management's biggest Q1 2026 reduction was Sandisk, cutting an estimated $45.2M.
  • AIGH Capital Management fully exited Day One Biopharmaceuticals in Q1 2026, selling an estimated $18.6M.
  • AIGH Capital Management's ten largest holdings make up 68% of its $733M portfolio in Q1 2026.
  • AIGH Capital Management opened 17 new positions and closed 8 in Q1 2026.
  • AIGH Capital Management's portfolio value rose 77% quarter-over-quarter to $733M.

Based on AIGH Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.